Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Progress in heavy particle radiotherapy]

H Tsujii1, H Tsuji, T Okumura

  • 1Proton Medical Research Center, University of Tsukuba.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biosynthetic transport of a major lysosomal membrane glycoprotein, lamp-1: convergence of biosynthetic and endocytic pathways occurs at three distinctive points.

Experimental cell research·1995
Same author

Expression of the Bombyx mori beta-tubulin-encoding gene in testis.

Gene·1995
Same author

[Progress of chronic hepatitis C to liver cirrhosis--comparison with chronic hepatitis B].

Nihon rinsho. Japanese journal of clinical medicine·1995
Same author

The human gene encoding the largest subunit of RNA polymerase II.

Gene·1995
Same author

Tumor cell attachment to laminin promotes degradation of the extracellular matrix and cell migration in high-metastatic clone cells of RCT sarcoma in vitro.

Japanese journal of cancer research : Gann·1995
Same author

Micro-assay to measure the allergenicity of a Kunitz-type soybean trypsin inhibitor toward Balb/c mice by using RBL-2H3 cells.

Bioscience, biotechnology, and biochemistry·1995
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

New ionizing radiations like protons and heavy ions offer precise cancer treatment. High LET particles provide greater radiobiological effects, enhancing therapeutic outcomes for various tumors.

Area of Science:

  • Explores advanced radiation oncology techniques utilizing novel ionizing particles for cancer therapy.

Context:

  • Ionizing radiation, including low Linear Energy Transfer (LET) and high LET particles, is increasingly employed in cancer treatment.
  • Protons and helium ions offer physical selectivity, while fast neutrons, heavy ions (carbon, neon), and negative pions exhibit higher radiobiological effectiveness (RBE).

Purpose:

  • To review the clinical applications and benefits of different types of ionizing radiation in cancer therapy.
  • To highlight the advantages of specific radiation types, such as improved dose distribution with heavy ions and carbon/neon ions.

Summary:

  • Low LET radiation (protons, helium ions) provides high physical selectivity, beneficial for certain cancers near critical organs.
  • High LET particles (fast neutrons, heavy ions, negative pions) demonstrate superior RBE and improved dose distribution.

Related Experiment Videos

  • Clinical data for protons, pions, and fast neutrons support ongoing heavy-ion therapy programs, with promising outcomes expected from facilities like HIMAC.

    • Impact:

    • Provides a comprehensive overview of advanced radiotherapy modalities, guiding future clinical research and treatment strategies.
    • Emphasizes the potential of heavy-ion therapy in improving cancer treatment efficacy and patient outcomes.